Improved methods for conducting multiplexed assays
A technology for detection reagents and detection labels, applied in laboratory containers, chemical instruments and methods, biochemical equipment and methods, etc., to achieve the effect of improving productivity and flexibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0268] Example 1 - Direct Assay Format
[0269] The procedure for the preparation and use of multiwell plates for direct assays is shown in Figure 2. The experimental layout, i.e. which oligonucleotide sequence is located in which binding domain of the multiwell assay plate, is annotated. Multiwell assay plates were obtained from MesoScale Discovery, a division of MesoScale Diagnostics, LLC (Rockville, MD). A working solution (550 uL) of each individual oligonucleotide sequence complement was prepared by diluting the stock solution of the sequence complement approximately 50-fold in Diluent100 (the stock solution of the oligonucleotide sequence complement and Diluent100 are available from MesoScaleDiscovery).
[0270] Using a bifunctional coupling reagent (4-( N -maleimidomethyl)-1-sulfosuccinimidyl cyclohexanecarboxylate ("SMCC")) and the conventional coupling scheme shown in Figure 5(d), using an oligo with a terminal thiol group Nucleotide labeling of each capture ant...
Embodiment 2
[0273] Example 2—Indirect Assay Format Using Oligonucleotide-SA Conjugates
[0274]The procedure for the preparation and use of multiwell plates for indirect assays using oligonucleotide-SA conjugates is shown in Figures 9(a)-(c). As in Example 1, annotate the experimental layout for the multi-well assay plate. A working solution (550 uL) of each individual oligonucleotide sequence complement conjugated to streptavidin (SA) was prepared by diluting the stock solution of the sequence complement approximately 50-fold in Diluent 100 (oligonucleotide Stock solutions of sequence complements and Diluent100 are available from MesoScale Discovery). A solution of biotinylated antibody was added to the working solution of the complement of the desired oligonucleotide sequence to prepare a set of each biotinylated capture antibody / oligonucleotide-SA mixture. The concentration of biotinylated antibody in the mixture ranged from about 5-30 ug / mL. The mixture was mixed gently for 30-45...
Embodiment 3
[0277] Example 3 - Indirect assay format using neat SA / biotinylated oligonucleotides
[0278] The procedure for the preparation and use of multiwell plates for indirect assays using biotinylated capture antibodies, neat streptavidin, and biotinylated oligonucleotides is shown in Figure 10(a)-(c). As in Example 1, annotate the experimental layout of the multiwell assay plate. A working excess (550 uL) of each individual oligonucleotide sequence complement conjugated to streptavidin (SA) was prepared by diluting the stock solution of the sequence complement approximately 50-fold in Diluent 100 (oligonucleotide Stock solutions of nucleotide sequence complements and Diluent100 are available from MesoScale Discovery). A solution of biotinylated antibody was added to the working solution of the complement of the desired oligonucleotide sequence to prepare a set of each biotinylated capture antibody / oligonucleotide-SA mixture. The concentration of biotinylated antibody in the mix...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 